 |
|
|
[ send your article ] Articles 03More articles: [newest], [05], [04], [03], [02], [01] Recently, respected experts from prostate cancer field published an important review of the current evidence surrounding the application of a number of the new and/or evolving treatments available such as newer technique known as vascular-targeted photodynamic therapy (VTFT). [ read full article ] A group of respected experts has addressed the available data related to the clinical use of prostate cancer techniques [ read full article ] A small international group of very highly respected experts has just published an important review of the current evidence surrounding the application of a number of the new and/or evolving treatments available for management of localized prostate cancer, with an emphasis on the potential of focal therapy. [ read full article ] The hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, with tumors usually regaining their hold within a couple of years. Now, researchers at Johns Hopkins have discovered critical differences in the hormone receptors on prostate cancer cells in patients who no longer respond to this therapy. [ read full article ] Could a natural substance effectively treat advanced prostate cancer? And could clinical trials of that potential cure be thwarted because drug companies know they can't make money out of a treatment that can't be patented? The answer to both those questions is "yes". [ read full article ] This the question has haunted many millions of men and their doctors as well for over one hundred years. And the true is there may not be an answer that can light the question. [ read full article ] Because there are so many options, physicians should consider first man's age, when they recommend various procedure. Then, they must think how a procedure will affect the future life quality of patient. In fact, a growing number of doctors say many prostate cancers are better off being left untreated. [ read full article ] New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2 (EPCA-2), may change the way men are screened for prostate cancer - a disease that kills tens of thousands of men every year. [ read full article ] An international study led by researchers at The Institute of Cancer Research will pave the way for a test to be used to better tailor treatments and hopefully extend the survival of men with aggressive forms of metastatic prostate cancer. [ read full article ] More than 65 percent of all prostate cancers are diagnosed in men over the age of 65. There is a twofold to elevenfold increase in developing prostate cancer when related to a first-degree male relative who also has developed prostate cancer. ` [ read full article ] Men with locally advanced prostate cancer will survive substantially longer when radiation is added to their treatment plan, Swedish researchers said. [ read full article ] Older men with early-stage prostate cancer who are given hormone therapy before radiation seed implant therapy face a 20 percent greater risk of dying than those who get radiation treatment alone, new research suggests. [ read full article ] Men receiving hormone-deprivation therapy for advanced but localized prostate cancer can develop bone loss as a side effect of the treatment. [ read full article ] Gene activity in prostate cancer is reminiscent of that in the developing fetal prostate, providing further evidence that all cancers are not equal, Johns Hopkins researchers report. The finding could help scientists investigate how to manipulate the genetic program [ read full article ] A major study by researchers from the Cancer Council Australia has found that even though more men are being diagnosed with prostate cancer, fewer are dying from the disease. [ read full article ] Cancer patients who are optimistic are better able manage the severity of their pain, while those with a strong sense of mastery (control over their environment) can control their fatigue more effectively while also keeping pain severity in check, new research shows. [ read full article ] University of Rochester researchers suggest that hormone therapy, the most common treatment for advanced prostate cancer, can boomerang to make the cancer more deadly. This conclusion is based on research on mice. [ read full article ] New study published in European Urology have shown that approximately 16% of patients with localised prostate cancer regret their treatment choice. European Urology (http://www.europeanurology.com), the official journal of the European Association of Urology, will be publishing an article [ read full article ] Prostate cancer is a fairly common cancer among U.S. men. In 2008, In the year 2008 in the United States, there were an estimated 186,320 new cases of prostate cancer and 28,660 deaths due to prostate cancer. [ read full article ] Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences. [ read full article ] More articles: [newest], [05], [04], [03], [02], [01] [ send your article ] NOTE: Issues on this site regarding prostate cancer and treatment options, are provided for information only, and are not meant to substitute for the advice of your own physician or other medical professional. Prostate-Report.org does not endorse any specific product, service or treatment. |
|